Drug Interactions between magnesium amino acids chelate and Uprima
This report displays the potential drug interactions for the following 2 drugs:
- magnesium amino acids chelate
- Uprima (apomorphine)
Interactions between your drugs
No interactions were found between magnesium amino acids chelate and Uprima. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
magnesium amino acids chelate
A total of 66 drugs are known to interact with magnesium amino acids chelate.
- Magnesium amino acids chelate is in the drug class minerals and electrolytes.
- Magnesium amino acids chelate is used to treat Hypomagnesemia.
Uprima
A total of 581 drugs are known to interact with Uprima.
- Uprima is in the drug class dopaminergic antiparkinsonism agents.
- Uprima is used to treat Parkinson's Disease.
Drug and food interactions
apomorphine food
Applies to: Uprima (apomorphine)
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Alcohol and apomorphine may have additive hypotensive and sedative effects. Coadministration of 0.6 or 0.3 g/kg of ethanol with apomorphine in healthy subjects resulted in greater decreases in blood pressure compared to apomorphine alone. The mean largest decrease (the mean of each subject's largest drop in blood pressure measured within 6 hours after apomorphine administration) in standing systolic and diastolic blood pressure was 6.7 and 8.4 mmHg, respectively, with apomorphine alone. When coadministered with 0.6 g/kg of ethanol (equivalent to approximately 3 standardized alcohol-containing beverages), the mean largest decrease in standing systolic and diastolic blood pressure was 11.3 and 12.6 mmHg, respectively (standing systolic and diastolic blood pressure decreased by as much as 61 and 51 mmHg, respectively, in this group). When coadministered with 0.3 g/kg of ethanol, the mean largest decrease in standing systolic and diastolic blood pressure was 8.4 and 7.1 mmHg, respectively.
MANAGEMENT: Patients should be advised to avoid consumption of alcohol during apomorphine treatment.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.